Analyst Research Report Snapshot

Title:

KAROLINSKA DEVELOPMENT - NEW HORIZONS

Price:

$10.00

Provider:

Edison Investment Research

Date:

02 Jul 2013

Pages:

2

Type:

AcrobatPDF

Companies referenced:

KDEV.ST

Available for Immediate Download
Summary:

Karolinska Development (KDEV) has made a significant step with the signing of its first deal flow agreements with research institutions outside of Sweden. The agreements with Ospedale San Raffaele and the University of Graz will provide access to life sciences investment opportunities from these centres. Meanwhile, several key catalysts are approaching in H213, including the final data from a Phase II trial of Axelar’s AXL1717 in NSCLC, which has already shown positive early signs of efficacy. Such data releases could lead to out-licensing deals, helping to realise the value of investments in its portfolio.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.